Invivyd(IVVD)
$0.45-0.02 (-5.32%)
IVVD
Invivyd stock drug pipeline
$0.45
At close:-0.02 (-5.32%)
Want to see IVVD full AI Analyst Report?
Invivyd (IVVD) Drug Pipeline
1,056 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Vyd2311-Sd, Vyd2311-Md | Covid-19 | Phase III | Recruiting | Study of VYD2311 for the Prevention of COVID-19 | Dec 18, 2025 | ― |
| Vyd2311 | Covid-19 | Phase I | Active Not Recruiting | A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants | Jul 18, 2024 | ― |
| Normal Saline, Vyd222 | Covid-19, Sars-Cov-2 | Phase III | Completed | A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2 | Sep 08, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Vyd2311-Sd, Vyd2311-Md | Phase III | Covid-19 | Recruiting | Study of VYD2311 for the Prevention of COVID-19 | Dec 18, 2025 | ― |
| Vyd2311 | Phase I | Covid-19 | Active Not Recruiting | A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants | Jul 18, 2024 | ― |
| Normal Saline, Vyd222 | Phase III | Covid-19, Sars-Cov-2 | Completed | A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2 | Sep 08, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Invivyd (IVVD) have in its pipeline
Invivyd IVVD is currently developing the following drugs: Vyd2311-Sd, Vyd2311-Md, Vyd2311, Normal Saline, Vyd222. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

